The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I - Blood pressure measurement, diagnosis and assessment of risk

Canadian Journal of Cardiology

Volumn 26, Issue 5, 2010, Pages 241-248

  Quinn, Robert R ^a   Hemmelgarn, Brenda R ^a   Padwal, Raj S ^b   Myers, Martin G ^c   Cloutier, Lyne ^d   Bolli, Peter ^e   McKay, Donald W ^f   Khan, Nadia A ^g   Hill, Michael D ^a   Mahon, Jeff ^h   Hackam, Daniel G ^h   Grover, Steven ⁱ   Wilson, Thomas ^j   Penner, Brian ^k   Burgess, Ellen ^a   McAlister, Finlay A ^b   Lamarre Cliche, Maxime ^l   McLean, Donna ^b   Schiffrin, Ernesto L ^m   Honos, George ^m   Mann, Karen ⁿ   Tremblay, Guy ^o   Milot, Alain ^p   Chockalingam, Arun ^q   Rabkin, Simon W ^g   Dawes, Martin ^r   Touyz, Rhian M ^s   Burns, Kevin D ^t   Ruzicka, Marcel ^t   Campbell, Norman R C ^u   Vallée, Michel ^v   Prasad, G V Ramesh ^w   Lebel, Marcel ^o   Tobe, Sheldon W ^w   more..

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^d UNIVERSITÉ DU QUÉBEC À TROIS RIVIÈRES   (Canada)

^e Ambulatory Internal Medicine Teaching Clinic   (Canada)

^f MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^g UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^h UNIVERSITY OF WESTERN ONTARIO   (Canada)

ⁱ MONTREAL GENERAL HOSPITAL   (Canada)

^j UNIVERSITY OF SASKATCHEWAN   (Canada)

^k UNIVERSITY OF MANITOBA   (Canada)

^l Institut de Recherches   (Canada)

^m MCGILL UNIVERSITY   (Canada)

ⁿ DALHOUSIE UNIVERSITY   (Canada)

^o LAVAL UNIVERSITY   (Canada)

^p UNIVERSITÉ LAVAL   (Canada)

^q SIMON FRASER UNIVERSITY   (Canada)

^r MCGILL UNIVERSITY   (Canada)

^s OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^t UNIVERSITY OF OTTAWA   (Canada)

^u UNIVERSITY OF CALGARY   (Canada)

^v MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^w UNIVERSITY OF TORONTO   (Canada)

more..

Author keywords

Blood pressure; Diagnosis; Guidelines; High blood pressure; Hypertension; Risk factors

Indexed keywords

ANABOLIC AGENT; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; CYCLOSPORIN; DECONGESTIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ERYTHROPOIETIN; MIDODRINE; MONOAMINE OXIDASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEX HORMONE; TACROLIMUS; VASOCONSTRICTOR AGENT;

ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; CREATININE BLOOD LEVEL; ECHOCARDIOGRAPHY; EDUCATION PROGRAM; EVIDENCE BASED MEDICINE; HUMAN; HYPERTENSION; HYPOKALEMIA; MEDLINE; PEER REVIEW; PRACTICE GUIDELINE; RISK ASSESSMENT; SIDE EFFECT;

EID: 77952309073     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0828-282X(10)70378-0     Document Type: Article

References (38)

1. Wolf-Maier K, Cooper RS, Kramer H, et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 2004;43:10-17
2. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet 2004;364:937-952 (Pubitemid 39208455)
3. Kannel WB. Blood pressure as a cardiovascular risk factor: Prevention and treatment. JAMA 1996;275:1571-1576 (Pubitemid 26154243)
4. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004;114:555-576
5. Padwal RS, Hemmelgarn BR, McAlister FA, et al. The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 - blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol 2007;23:529-538
6. Khan NA, Hemmelgarn B, Padwal R, et al. The 2007 Canadian Hypertension Education Program Recommendations for the management of hypertension: Part 2 - therapy. Can J Cardiol 2007;23:537-550
7. Padwal RS, Hemmelgarn BR, Khan NA, et al. The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 - blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol 2008;24:455-463
8. Khan NA, Hemmelgarn B, Herman RJ, et al. The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2 - therapy. Can J Cardiol 2008;24:465-475
9. Khan NA, Hemmelgarn B, Herman RJ, et al. The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2 - therapy. Can J Cardiol 2009;25:287-298
10. Padwal RS, Hemmelgarn BR, Khan NA, et al. The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 - blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol 2009;25:279-286
11. Zarnke KB, Campbell NR, McAlister FA, LevineM. A novel process for updating recommendations for managing hypertension: Rationale and methods. Can J Cardiol 2000;16:1094-1102
12. McAlister FA. The Canadian Hypertension Education Program - a unique Canadian initiative. Can J Cardiol 2006;22:559-564 (Pubitemid 44044211)
13. Beckett L, Godwin M. The BpTRU automatic blood pressure monitor compared to 24 hour ambulatory blood pressure monitoring in the assessment of blood pressure in patients with hypertension. BMC Cardiovasc Disord 2005;5:18. (Pubitemid 41460660)
14. Myers MG, Valdivieso M, Kiss A. Consistent relationship between automated office blood pressure recorded in different settings. Blood Press Monit 2009;14:108-111
15. Campbell NR, Conradson HE, Kang J, Brant R, Anderson T. Automated assessment of blood pressure using BpTRU compared with assessments by a trained technician and a clinic nurse. Blood Press Monit 2005;10:257-262 (Pubitemid 41502883)
16. Myers MG, McInnis NH, Fodor GJ, Leenen FH. Comparison between an automated and manual sphygmomanometer in a population survey. Am J Hypertens 2008;21:280-283 (Pubitemid 351323269)
17. Myers MG. Automated blood pressure measurement in routine clinical practice. Blood Press Monit 2006;11:59-62. (Pubitemid 44090017)
18. Myers MG, Godwin M. Automated measurement of blood pressure in routine clinical practice. J Clin Hypertens (Greenwich) 2007;9:267-270
19. Wright JM, Mattu GS, Perry Jr TL, et al. Validation of a new algorithm for the BPM-100 electronic oscillometric office blood pressure monitor. Blood Press Monit 2001;6:161-165
20. White WB, Anwar YA. Evaluation of the overall efficacy of the Omron office digital blood pressure HEM-907 monitor in adults. Blood Press Monit 2001;6:107-110
21. Stergiou GS, Tzamouranis D, Protogerou A, Nasothimiou E, Kapralos C. Validation of the Microlife Watch BP office professional device for office blood pressure measurement according to the international protocol. Blood Press Monit 2008;13:299-303.
22. Myers MG, Valdivieso M, Kiss A. Use of automated office blood pressure measurement to reduce the white coat response. J Hypertens 2009;27:280-286
23. Campbell NR, McKay DW, Conradson H, Lonn E, Title LM, Anderson T. Automated oscillometric blood pressure versus auscultatory blood pressure as a predictor of carotid intima-medial thickness in male firefighters. J Hum Hypertens 2007;21:588-590 (Pubitemid 47018634)
24. Hemmelgarn BR, McAlister FA, Myers MG, et al. The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 - blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol 2005;21:645-656
25. Topol EJ, Lauer MS. The rudimentary phase of personalised medicine: Coronary risk scores. Lancet 2003;362:1776-1777
26. Hemmelgarn BR, McAlister FA, Grover S, et al. The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 - blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol 2006;22:573-581
27. Grover SA, Hemmelgarn B, Joseph K, Milot A, Tremblay G. The role of global risk assessment in hypertension therapy. Can J Cardiol 2006;22:606-613 (Pubitemid 44044217)
28. Anderson KM, Wilson PW, Kannel WB. An updated coronary risk profile. A statement for health professionals. Circulation 1991;83:356.
29. Deber RB, Kraetschmer N, Irvine J. What role do patients wish to play in treatment decision making? Arch Intern Med 1996;156:1414-1420
30. D'Agostino RB Sr, Grundy S, Sullivan LM, Wilson P. Validation of the Framingham coronary heart disease prediction scores: Results of a multiple ethnic groups investigation. JAMA 2001;286:180-187 (Pubitemid 32640849)
31. D'Agostino RB, Russell MW, Huse DM, et al. Primary and subsequent coronary risk appraisal: New results from the Framingham study. Am Heart J 2000;139:272-281
32. Grover SA, Paquet S, Levinton C, et al. Estimating the benefits of modifying risk factors of cardiovascular disease: A comparison of primary vs secondary prevention. Arch Intern Med 1998;158:655-662 (Pubitemid 28144824)
33. Conroy RM, Pyorala K, Fitzgerald AP, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: The SCORE project. Eur Heart J 2003;24:987-1003. (Pubitemid 36712275)
34. Ankle Brachial Index Collaboration, Fowkes FG, Murray GD, et al. Ankle brachial index combined with Framingham risk score to predict cardiovascular events and mortality: A meta-analysis. JAMA 2008;300:197-208.
35. Cooney MT, Dudina AL, Graham IM. Value and limitations of existing scores for the assessment of cardiovascular risk: A review for clinicians. J Am Coll Cardiol 2009;54:1209-1227
36. Lewington S, Clarke R, Qizilbash N, Peto R. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903. (Pubitemid 35472129)
37. Grover SA, Lowensteyn I, Joseph L, et al. Patient knowledge of coronary risk profile improves the effectiveness of dyslipidemia therapy: The CHECK-UP study: A randomized controlled trial. Arch Intern Med 2007;167:2296-2303 (Pubitemid 350179523)
38. Benner JS, Erhardt L, Flammer M, et al. A novel programme to evaluate and communicate 10-year risk of CHD reduces predicted risk and improves patients' modifiable risk factor profile. Int J Clin Pract 2008;62:1484-1498